537
Participants
Start Date
March 8, 2023
Primary Completion Date
October 13, 2025
Study Completion Date
August 5, 2029
DOR/ISL
Fixed dose combination tablet containing DOR/ISL 100 mg/0.25 mg taken by mouth.
BIC/FTC/TAF
Fixed dose combination tablet containing BIC/FTC/TAF 50 mg/200 mg/25 mg taken by mouth.
Placebo to DOR/ISL
Placebo tablet matched to DOR/ISL tablet taken by mouth.
Placebo to BIC/FTC/TAF
Placebo tablet matched to BIC/FTC/TAF tablet taken by mouth.
Hôpitaux Universitaires de Genève (HUG)-Infectious Disease Department ( Site 8150), Geneva
Perinatal HIV Research Unit (PHRU)-Adult Treatment and Research ( Site 6654), Johannesburg
Helen Joseph Hospital-Clinical HIV Research Unit ( Site 6661), Johannesburg
Ezintsha-Clinical Research Site ( Site 6656), Johannesburg
Human Sciences Research Council-Centre for Community Based Research ( Site 6664), Pietermaritzburg
Qhakaza Mbokodo Research Clinic ( Site 6659), Ladysmith
University Hospital Basel-Infectiology ( Site 8151), Basel
Wentworth Hospital ( Site 6653), Durban
Family Clinical Research Unit (Fam-Cru)-Adult Infectious Diseases ( Site 6657), Cape Town
Be Part Yoluntu Centre ( Site 6650), Paarl
Desmond Tutu Health Foundation ( Site 6651), Cape Town
Hadassah Medical Center-Infecious Disease ( Site 6752), Jerusalem
Josha Research ( Site 6652), Bloemfontein
Columbia University Irving Medical Center-Division of Infectious Diseases ( Site 5688), New York
"Instituto Dermatológico y Cirugía de Piel Dr. Huberto Bogaert Díaz ( Site 8250)", Santo Domingo de Guzman
HIV Netherlands Australia Thailand Research Collaboration ( Site 7851), Bangkok
Hospital Pulau Pinang ( Site 7779), George Town
Jacobi Medical Center ( Site 5683), The Bronx
Faculty of Medicine Siriraj Hospital-Preventive and social ( Site 7850), Bangkok
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 7251), Mexico City
Washington Health Institute ( Site 5689), Washington D.C.
ICH Study Center GmbH & Co. KG ( Site 6259), Hamburg
Universitaetsklinikum Hamburg-Eppendorf-Infektiologie ( Site 6260), Hamburg
Regional Center for Infectious Diseases ( Site 5687), Greensboro
HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON-Unidad de Enfermedades Infecciosas ( Site 6353), Madrid
Hospital Universitario Fundación Jiménez Díaz-Internal Medicine. Infectious disease ( Site 6357), Madrid
Hospital Universitario Ramón y Cajal-ENFERMEDADES INFECCIOSAS ( Site 6361), Madrid
Hospital Universitario 12 de Octubre ( Site 6355), Madrid
Hospital Universitario La Paz ( Site 6354), Madrid
Atrium Health Infectious Disease Kenilworth - Charlotte ( Site 5675), Charlotte
Hospital Universitario Virgen de la Victoria ( Site 6359), Málaga
Metro Infectious Diseases Consultants L.L.C. ( Site 5653), Decatur
Emory University and Grady Health System-Medicine ( Site 5690), Atlanta
Emory University Hospital Midtown Infectious Disease Clinic ( Site 5673), Atlanta
Atlanta I.D. Group ( Site 5680), Atlanta
Mercer University, Department of Internal Medicine ( Site 5655), Macon
Orlando Immunology Center ( Site 5654), Orlando
AHF The Kinder Medical Group ( Site 5672), Miami
AHF South Beach ( Site 5663), Miami Beach
Triple O Research Institute, P.A ( Site 5666), West Palm Beach
CAN Community Health - Sarasota ( Site 5668), Sarasota
Midway Immunology and Research Center ( Site 5657), Ft. Pierce
KEMRI-CMR-RCTP ( Site 8650), Kisumu
Hospital Sungai Buloh ( Site 7778), Sungai Buloh
Be Well Medical Center ( Site 5650), Berkley
Henry Ford Hospital ( Site 5667), Detroit
Research Institute for Health Sciences-Research Institute for Health Sciences Building 1 ( Site 7852, Chiang Mai
Hospital Kuala Lumpur ( Site 7773), Kuala Lumpur
Universitätsklinikum Bonn-Immunologie ( Site 6250), Bonn
University Malaya Medical Centre-Clinical Investigation Centre (CIC) ( Site 7777), Lembah Pantai
Tourcoing Hospital ( Site 6150), Tourcoing
Rush University Medical Center-Infectious Disease ( Site 5671), Chicago
University of Illinois at Chicago-Project WISH ( Site 5685), Chicago
Howard Brown Health Center-Clinical Research ( Site 5665), Chicago
KC CARE Health Center-Clinical Trials ( Site 5670), Kansas City
Hospital Selayang ( Site 7770), Batu Caves
Hôpital Saint-Louis ( Site 6159), Paris
Pitie Salpetriere University Hospital ( Site 6156), Paris
Hôpital Bichat - Claude-Bernard ( Site 6162), Paris
Prism Health North Texas, Oak Cliff Health Center ( Site 5660), Dallas
North Texas Infectious Diseases Consultants, P.A ( Site 5651), Dallas
Hôpital Saint Antoine ( Site 6158), Paris
DCOL Center for Clinical Research ( Site 5664), Longview
Texas Centers for Infectious Disease Associates ( Site 5656), Fort Worth
St Hope Foundation ( Site 5659), Bellaire
Central Texas Clinical Research ( Site 5661), Austin
Universitaetsklinikum Freiburg ( Site 6256), Freiburg
AXCES Research - Texas - El Paso ( Site 5692), El Paso
Vivent Health ( Site 5694), Denver
Klinikum der Ludwig-Maximilians-Universitaet Muenchen-Medizinische Klinik und Poliklinik IV, Sektio, München
Pueblo Family Physicians ( Site 5674), Phoenix
Jubilee Clinical Research ( Site 5679), Las Vegas
Las Vegas Research Center ( Site 5691), Las Vegas
Ruane Clinical Research Group, Inc ( Site 5658), Los Angeles
Pacific Oaks Medical Group ( Site 5681), Beverly Hills
Hôpital Avicenne ( Site 6160), Bobigny
Sarawak General Hospital ( Site 7772), Kuching
Hospital Universitario San Ignacio-Infectious ( Site 6053), Bogotá
Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia ( Site 6051), Bogotá
Fundación Valle del Lili ( Site 6052), Santiago de Cali
Rambam Health Care Campus-Institute of Allergy, Clinical Immunology, ( Site 6751), Haifa
Clinica Universidad Catolica del Maule ( Site 5954), Talca
Hospital hernan henriquez aravena de temuco-Unidad de Investigación Clínica ( Site 5955), Temuco
Sheba Medical Center-HIV unit ( Site 6753), Ramat Gan
Sourasky Medical Center ( Site 6754), Tel Aviv
Biomedica Research Group-Infectology ( Site 5951), Santiago
Espacio Eme ( Site 5952), Santiago
Centro de Investigacion Clinicadela Universidad Catolica ( Site 5953), Santiago
Universidad de Chile - Hospital Clínico Universidad de Chile-Inmunologia Alergia y VIH ( Site 5950), Santiago
ID Care ( Site 5676), Hillsborough
Saint Michael's Medical Center ( Site 5682), Newark
University of Cincinnati Medical Center-Infectious Diseases - Outpatient ( Site 5662), Cincinnati
Fundación Huésped ( Site 5850), CABA
Instituto de Investigaciones Clínicas Mar del Plata ( Site 5854), Mar del Plata
Instituto CAICI SRL ( Site 5852), Rosario
Fundación IDEAA ( Site 5851), Buenos Aires
Instituto Oulton ( Site 5853), Córdoba
Hamilton Health Sciences-Urgent Care Centre ( Site 5750), Hamilton
Toronto General Hospital ( Site 5753), Toronto
Clinique Medicale lActuel ( Site 5752), Montreal
McGill University Health Centre ( Site 5751), Montreal
Regina General Hospital ( Site 5754), Regina
Ciensalud Ips S A S ( Site 6050), Barranquilla
Clinica de la Costa S.A.S. ( Site 6055), Barranquilla
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet ( Site 6153), Nice
CLINIPHARM ( Site 8352), Guatemala City
Clínica Médica Especializada en Pediatría e Infectología Pediátrica - Dr. Mario Melgar ( Site 8350), Guatemala City
CELAN,S.A ( Site 8351), Guatemala City
National Hospital Organization Nagoya Medical Center ( Site 6953), Nagoya
Tokyo Medical University Hospital ( Site 6954), Shinjuku-ku
Center Hospital of the National Center for Global Health and Medicine ( Site 6951), Shinjyuku-ku
National Hospital Organization Osaka National Hospital ( Site 6952), Osaka
CCR KEMRI (Center for Clinical Research) ( Site 8652), Nairobi
PHRD KEMRI (Partners in Health Research & Development) ( Site 8651), Nairobi
Hospital Sultanah Bahiyah ( Site 7776), Alor Star
Ponce Medical School Foundation Inc. ( Site 7452), Ponce
Clinical Research Puerto Rico ( Site 7450), San Juan
HOPE Clinical Research ( Site 7451), San Juan
Madibeng Centre for Research ( Site 6660), Brits
Hospital General Universitario de Elche-Infectius Disease ( Site 6358), Elche
Hospital Germans Trias i Pujol-Fundació Lluita contra la Sida ( Site 6351), Badalona
HOSPITAL CLÍNIC DE BARCELONA-Infection Day Hospital ( Site 6350), Barcelona
Hospital Universitari de Bellvitge ( Site 6360), L'Hospitalet de Llobregat,Barcelona
Hospital Universitari Vall d'Hebron-Infectious Diseases: HIV unit ( Site 6352), Barcelona
Hacettepe Universite Hastaneleri ( Site 7650), Altindağ
Ankara Bilkent Şehir Hastanesi-Infectious Disease and Clinical Microbiology ( Site 7659), Ankara
Southmead Hospital ( Site 7952), Bristol
Royal London Hospital ( Site 7951), London
The Hathersage Centre ( Site 7953), Manchester
King's College Hospital ( Site 7950), London
The Mortimer Market Centre for Sexual Health and HIV Research ( Site 7954), London
Merck Sharp & Dohme LLC
INDUSTRY